Advice abounds regarding FDA’s updated informed consent guidance and how to address its changes as if the Draft Guidance were already policy. Insufficient attention has been given to problematic areas that deserve comment. This Webinar will review the various perspectives of all parties involved in clinical research regarding what is beneficial and what is of true concern in the Draft Guidance. “It’s Not Policy Yet” will keep you up to date with regard to what is happening with this important guidance. Presented by senior executives in the pharmaceutical industry from USA and Canada.
Please fill out the form to download our webinar "It’s Not Policy Yet".